ASDS 2024: Galderma’s Liquid Toxin Shows Long-term Safety for Frown Lines, Crow’s Feet
RelabotulinumtoxinA (Relfydess, Galderma) showed long-term safety for frown lines and crow’s feet after repeated injections, according to new data from the READY-4 clinical trial presented at the American Society for Dermatologic Surgery (ASDS) 2024 Annual Meeting in Orlando, FL. The READY-4 study met its primary and secondary endpoints, with less than one in five participants […]